0001493152-22-013996.txt : 20220516 0001493152-22-013996.hdr.sgml : 20220516 20220516174420 ACCESSION NUMBER: 0001493152-22-013996 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220516 FILED AS OF DATE: 20220516 DATE AS OF CHANGE: 20220516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JACOB GARY S CENTRAL INDEX KEY: 0001266802 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41386 FILM NUMBER: 22931320 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OKYO Pharma Ltd CENTRAL INDEX KEY: 0001849296 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 55 PARK LANE CITY: LONDON STATE: X0 ZIP: W1K 1NA BUSINESS PHONE: 44 (0) 207 495 2379 MAIL ADDRESS: STREET 1: 55 PARK LANE CITY: LONDON STATE: X0 ZIP: W1K 1NA 3 1 ownership.xml X0206 3 2022-05-16 0 0001849296 OKYO Pharma Ltd OKYO 0001266802 JACOB GARY S C/O OKYO PHARMA LIMITED MARTELLO COURT ADMIRAL PARK ST. PETER PORT Y7 GY1 3HB GUERNSEY 1 1 0 0 Chief Executive Officer Option (right to buy) 0.0653 2029-01-06 Ordinary Shares 40000000 D Option (right to buy) 0.0640 2031-08-31 Ordinary Shares 13000000 D 25% will vest each year on January 7, beginning on January 6, 2021. 25% will vest each year on January 7, beginning on August 31, 2021. /s/ Gary S. Jacob 2022-05-16